Show simple item record

dc.contributor.authorGonçalves Marcelino, Sandra 
dc.contributor.authorMandim, Filipa
dc.contributor.authorOludemi , Taofiq Ayodele 
dc.contributor.authorSão Pedro Pires, Tânia Cristina 
dc.contributor.authorFinimundy, Tiane C.
dc.contributor.authorPrieto Lage, Miguel Ángel 
dc.contributor.authorBarros, Lillian
dc.date.accessioned2023-09-22T07:53:59Z
dc.date.available2023-09-22T07:53:59Z
dc.date.issued2023-02-23
dc.identifier.citationPharmaceuticals, 16(3): 342 (2023)spa
dc.identifier.issn14248247
dc.identifier.urihttp://hdl.handle.net/11093/5146
dc.description.abstractDue to a lack of innovative valorization strategies, pomegranate processing generates a significant amount of residues with a negative environmental footprint. These by-products are a rich source of bioactive compounds with functional and medicinal benefits. This study reports the valorization of pomegranate leaves as a source of bioactive ingredients using maceration, ultrasound, and microwave-assisted extraction techniques. The phenolic composition of the leaf extracts was analyzed using an HPLC-DAD-ESI/MSn system. The extracts’ antioxidant, antimicrobial, cytotoxic, anti-inflammatory, and skin-beneficial properties were determined using validated in vitro methodologies. The results showed that gallic acid, (-)-epicatechin, and granatin B were the most abundant compounds in the three hydroethanolic extracts (between 0.95 and 1.45, 0.7 and 2.4, and 0.133 and 3.0 mg/g, respectively). The leaf extracts revealed broad-spectrum antimicrobial effects against clinical and food pathogens. They also presented antioxidant potential and cytotoxic effects against all tested cancer cell lines. In addition, tyrosinase activity was also verified. The tested concentrations (50–400 µg/mL) ensured a cellular viability higher than 70% in both keratinocyte and fibroblast skin cell lines. The obtained results indicate that the pomegranate leaves could be used as a low-cost source of value-added functional ingredients for potential nutraceutical and cosmeceutical applications.spa
dc.description.sponsorshipMinisterio de Ciencia e Innovación | Ref. RYC-2017-22891spa
dc.description.sponsorshipMinisterio de Ciencia e Innovación | Ref. FJC2019-042549-Ispa
dc.description.sponsorshipMinisterio de Ciencia e Innovación | Ref. FJC20120-045405-Ispa
dc.description.sponsorshipFundação para a Ciência e a Tecnologia | Ref. UIDB/00690/2020spa
dc.description.sponsorshipFundação para a Ciência e a Tecnologia | Ref. UIDP/00690/2020spa
dc.description.sponsorshipFundação para a Ciência e a Tecnologia | Ref. LA/P/0007/2021spa
dc.description.sponsorshipFundação para a Ciência e a Tecnologia | Ref. SFRH/BD/146614/2019spa
dc.language.isoengspa
dc.publisherPharmaceuticalsspa
dc.relationinfo:eu-repo/grantAgreement/MICINN//RYC-2017-22891/ES
dc.relationinfo:eu-repo/grantAgreement/MICINN//FJC2019-042549-I/ES
dc.relationinfo:eu-repo/grantAgreement/MICINN//FJC20120-045405-I/ES
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleValorization of Punica granatum L. leaves extracts as a source of bioactive moleculesen
dc.typearticlespa
dc.rights.accessRightsopenAccessspa
dc.identifier.doi10.3390/ph16030342
dc.identifier.editorhttps://www.mdpi.com/1424-8247/16/3/342spa
dc.publisher.departamentoQuímica analítica e alimentariaspa
dc.publisher.grupoinvestigacionInvestigacións Agrarias e Alimentariasspa
dc.subject.unesco2301.03 Análisis Cromatográficospa
dc.date.updated2023-09-22T07:44:08Z
dc.computerCitationpub_title=Pharmaceuticals|volume=16|journal_number=3|start_pag=342|end_pag=spa


Files in this item

[PDF]

    Show simple item record

    Attribution 4.0 International
    Except where otherwise noted, this item's license is described as Attribution 4.0 International